Table 5.
Comparison of BCVA for Central, Paracentral and Peripheral Ulcers (logMAR)
Ulcer Location | ISVCZ | ISAMB | ISNTM | P value |
---|---|---|---|---|
Central | n=2 | n=2 | n=2 | |
Baseline | 2.7±0.22 | 2.7±0.5 | 2.5±0.12 | 0.9 |
Final follow-up | 2.15±0.12 | 2.7±0.14 | 2.08±0.13 | 0.1 |
Paracentral | n=13 | n=14 | n=14 | |
Baseline | 2.23±0.7 | 2.3±0.3 | 2.25±0.34 | 0.9 |
Final follow-up | 1.28±0.6 | 1.3±0.5 | 1.27±0.7 | 0.7 |
Peripheral | n=5 | n=4 | n=4 | |
Baseline | 1.74±0.6 | 1.76± 0.3 | 1.85±0.4 | 0.7 |
Final follow-up | 1±0.2 | 1.12±0.6 | 0.8±0.3 | 0.3 |
Abbreviations: ISVCZ, intrastromal voriconazole; ISAMB, intrastromal amphotericin B; ISNTM, intrastromal natamycin; BCVA, best corrected visual acuity.